Testicular cancer deaths double with after 40 diagnosis

	Tweet

Men diagnosed with testicular cancer at 40 years of age or older have twice the risk of dying from the disease as younger patients, according to a study of nearly 28,000 men.

This was true even when initial treatment and the extent of the disease were taken into account, according to findings published in the Journal of Clinical Oncology.

“This study comprehensively documents, for the first time, to our knowledge, the effect of age on TC-specific mortality, while taking into account disease characteristics, treatment factors and socio-demographic variables,” wrote Lois Travis, of the University of Rochester Medical Center, New York, along with colleagues from Oslo, Norway.

The research is based on data from the Surveillance, Epidemiology and End Results program, a source for U.S. cancer statistics at the U.S. National Cancer Institute. Travis and her team calculated hazard ratios for 10-year testicular cancer mortality.

Mortality was doubled in patients diagnosed over the age of 40, the study found. But, those diagnosed after 1987 were less likely to die during follow-up than men diagnosed earlier, possibly due to the introduction of a certain kind of chemotherapy about 10 years earlier.

“The question, however, remains whether association between socioeconomic variables and mortality reflect differences in the health care system’s ability to offer optimal treatment, the patient’s willingness to accept intensive treatment with a non-negligible risk of adverse effects, or the physician’s knowledge of optimal treatment approaches,” they wrote.

Several factors may account for the age-related mortality difference, including the fact that many older patients are often not treated with the same intensity as younger patients, the researchers said.

The researchers recommended giving more attention to the care of older patients as well as those of people of lower socioeconomic status for the best results.

“In a cancer that is so highly curable, any influence that confers an increased risk of disease-specific mortality must be identified, and interventional strategies adopted,” they said.

###
SOURCE

RELATED STORIES:
Testicular cancer survivors may face lung problems   Canisius College and Roswell Park Cancer Institute Launch “Check Yo Nutz” Testicular Cancer Awareness Campaign   Drug avoids radiation for early testicular cancer   Second gene linked to familial testicular cancer   Marijuana Use Linked to Increased Risk of Testicular Cancer   Treatment not testicular cancer poses greatest risk to survivors’ long-term health   Spike in testicular cancer is focus   Researchers Discover Genetic Risk Factor for Testicular Cancer   Fetal Exposure to Radiation Increases Risk of Testicular Cancer   Testicular cancer may raise risk of heart attack   Relatives of boys with sexual birth defects not at risk for testicular germ cell cancer   Heat Therapy for Cancer May be Key to “Lance Armstrong Effect”   Lance Armstrong, top doctors launch cancer quest   Birth weight tied to testicular cancer risk   Comic Books Featuring ‘Super Heroes’ Educate Young Men About Testicular Cancer   Scientists find genes linked to testicular cancer   Couples more likely to divorce if spouse develops cervical or testicular cancer   Long-term testicular cancer survivors at high risk for neurological side effects   Testicular Cancer Gauge Often Not Used

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

The fact that cancer can sneak up on anyone is extremely scary. But to top it off now you have to worry about age making the death risk twice as high. Not exactly the kind of news everyone is looking for in regards to cancer information. Hopefully this will increase peoples awareness and they will put more into seeing a doctor on a regular basis.

posted by Testicular Cancer Center on 02/10/2011 at 6:06 am -08:00